Results from a new study published in the Proceedings of the National Academy of Sciences have found that a type of bio-engineered skin graft was able to produce molecules that controlled blood pressure in mice. The skin cells were altered using a retrovirus to insert a gene into them, and then they were applied as grafts. The scientists say this approach is not difficult, and it could be used to treat a number of diseases besides hypertension as well.
Read full story >